Back to top
more

Fortress Biotech, Inc. (FBIO)

(Delayed Data from NSDQ)

$2.80 USD

2.80
667,430

+0.10 (3.70%)

Updated Jan 22, 2020 03:57 PM ET

Add to portfolio

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1
2
3
4
5
S&P
Strong Buy
Buy
Hold
Sell
Strong Sell
500
24.66%
17.94%
9.57%
5.30%
2.19%
10.75%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

NA Value | NA Growth | NA Momentum | NA VGM

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

View All Zacks #1 Ranked Stocks

Trades from $1

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Balance Sheet

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

Fiscal Year End for Fortress Biotech, Inc. falls in the month of December.

All items in Millions except Per Share data.

12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Assets          
Cash & Equivalents NA 83 153 92 98
Receivables NA 8 17 9 0
Notes Receivable NA 0 0 0 0
Inventories NA 1 0 0 0
Other Current Assets NA 20 13 9 2
Total Current Assets NA 111 183 110 100
Net Property & Equipment NA 12 10 7 0
Investments & Advances NA 0 1 1 2
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 0 0 0 0
Intangibles NA 1 34 36 1
Deposits & Other Assets NA 16 18 16 15
Total Assets NA 141 246 171 119
Liabilities & Shareholders Equity 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Notes Payable NA 19 13 2 0
Accounts Payable NA 34 36 24 2
Current Portion Long-Term Debt NA 0 0 0 0
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 0 10 12 9
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 2 8 18 0
Total Current Liabilities NA 56 67 57 11
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 0 0 0 0
Convertible Debt NA 0 10 4 0
Long-Term Debt NA 60 43 23 23
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 5 5 5 1
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 121 125 88 34
Shareholders Equity 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 1 1 0 0
Capital Surplus NA 397 364 284 247
Retained Earnings NA -396 -312 -245 -190
Other Equity NA 18 68 44 27
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity NA 20 121 83 84
Total Liabilities & Shareholder's Equity NA 141 246 171 119
Total Common Equity 0 20 121 83 84
Shares Outstanding 70.70 56.60 50.60 48.80 47.10
Book Value Per Share 0.00 0.35 2.38 1.70 1.79

Fiscal Year End for Fortress Biotech, Inc. falls in the month of December.

All items in Millions except Per Share data.

12/31/2019 9/30/2019 6/30/2019 3/31/2019 12/31/2018
Assets          
Cash & Equivalents NA 155 154 121 83
Receivables NA 6 5 10 8
Notes Receivable NA 0 0 0 0
Inventories NA 1 1 1 1
Other Current Assets NA 4 3 4 20
Total Current Assets NA 166 164 137 111
Net Property & Equipment NA 12 12 12 12
Investments & Advances NA 11 11 11 0
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 0 0 0 0
Intangibles NA 8 1 1 1
Deposits & Other Assets NA 24 40 40 16
Total Assets NA 222 227 201 141
Liabilities & Shareholders Equity 12/31/2019 9/30/2019 6/30/2019 3/31/2019 12/31/2018
Notes Payable NA 15 9 9 19
Accounts Payable NA 29 24 37 34
Current Portion Long-Term Debt NA 2 2 1 0
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 0 0 0 0
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 1 1 1 2
Total Current Liabilities NA 47 36 49 56
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 0 0 0 0
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 93 99 99 60
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 2 2 5
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 147 137 150 121
Shareholders Equity 12/31/2019 9/30/2019 6/30/2019 3/31/2019 12/31/2018
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 1 1 1 1
Capital Surplus NA 446 439 415 397
Retained Earnings NA -421 -408 -395 -396
Other Equity NA 49 58 30 18
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity NA 75 90 51 20
Total Liabilities & Shareholder's Equity NA 222 227 201 141
Total Common Equity 0 75 90 51 20
Shares Outstanding 70.70 69.00 65.20 64.20 56.60
Book Value Per Share 0.00 1.09 1.38 0.79 0.35